Chevalier Biosciences LLC

Chevalier Biosciences LLC  features a disruptive, dual path commercialization strategy for our breakthrough proprietary recombinant protein.  In our synergistic space of equine wound care, we target a unique customer population of over 1M high net worth women  (90% of horse owners) for whom we can powerfully validate the technology, while avoiding the noise and clutter of the cosmeceutical space.  This complimentary strategy allows the brand to enter the equine market to validate the cellular reparative qualities of our recombinant protein and obliquely access an enormous market when applied to topical cosmeceutical skin care.  We have assembled an extraordinary management team with successful experience in both the biotech and cosmeceutical space.